{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:16:11Z","timestamp":1793661371056,"version":"4.5.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472785"],"award-info":[{"award-number":["82472785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573774"],"award-info":[{"award-number":["82573774"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010881","name":"Suzhou City Department of Science and Technology","doi-asserted-by":"publisher","award":["GSWS2023024"],"award-info":[{"award-number":["GSWS2023024"]}],"id":[{"id":"10.13039\/501100010881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","award":["Z-2021-46-2503"],"award-info":[{"award-number":["Z-2021-46-2503"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20230211"],"award-info":[{"award-number":["BK20230211"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.phymed.2026.158611","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:38:07Z","timestamp":1784561887000},"page":"158611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Targeting KIF11 degradation: Oxypeucedanin inhibits lung adenocarcinoma progression by disrupting the MCM2-CDK1 signaling pathway"],"prefix":"10.1016","volume":"160","author":[{"given":"Wenting","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhua","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuna","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-an","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0226-5638","authenticated-orcid":false,"given":"Zhaowei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1100-5440","authenticated-orcid":false,"given":"Jianjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2026.158611_bib0001","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s00210-023-02748-3","article-title":"Anti-proliferative activity of chitosan-coated oxypeucedanin nano-chitosomes (COPD-NCs) against human HT-29 colon cancer cells: in vitro study","volume":"397","author":"Almohammed","year":"2024","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.phymed.2026.158611_bib0002","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2026.158611_bib0003","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2026.158611_bib0004","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1534\/genetics.115.186452","article-title":"Chromosome Duplication in Saccharomyces cerevisiae","volume":"203","author":"Bell","year":"2016","journal-title":"Genetics"},{"key":"10.1016\/j.phymed.2026.158611_bib0005","first-page":"355","article-title":"Mechanisms for initiating cellular DNA replication","author":"Bleichert","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.phymed.2026.158611_bib0006","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phymed.2026.158611_bib0007","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phymed.2026.158611_bib0008","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/cac2.12359","article-title":"Non-small cell lung cancer in China","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun. (Lond)"},{"key":"10.1016\/j.phymed.2026.158611_bib0009","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","article-title":"Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management","volume":"19","author":"Cooper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phymed.2026.158611_bib0011","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.7150\/jca.22691","article-title":"Expression of minichromosome maintenance proteins (MCM) and cancer prognosis: a meta-analysis","volume":"9","author":"Gou","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.phymed.2026.158611_bib0012","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10637-013-9926-y","article-title":"Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer","volume":"31","author":"Jones","year":"2013","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.phymed.2026.158611_bib0013","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/02841860902824925","article-title":"Anti-tumor activity of oxypeucedanin from Ostericum koreanum against human prostate carcinoma DU145 cells","volume":"48","author":"Kang","year":"2009","journal-title":"Acta Oncol."},{"key":"10.1016\/j.phymed.2026.158611_bib0014","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/neuonc\/noad252","article-title":"Abrogation of the G2\/M checkpoint as a chemosensitization approach for alkylating agents","volume":"26","author":"Lang","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.phymed.2026.158611_bib0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10637-007-9097-9","article-title":"A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group trial","volume":"26","author":"Lee","year":"2008","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.phymed.2026.158611_bib0016","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10637-015-0211-0","article-title":"First-in-human phase 1 study of filanesib (ARRY-520), a kinesin spindle protein inhibitor, in patients with advanced solid tumors","volume":"33","author":"LoRusso","year":"2015","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.phymed.2026.158611_bib0017","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S2213-2600(24)00428-4","article-title":"Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study","volume":"13","author":"Luo","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.phymed.2026.158611_bib0018","first-page":"1572","article-title":"Investigation of uridine in anti-aging-related diseases based on network pharmacology, molecular docking and cell experimental validation","volume":"35","author":"Ma","year":"2025","journal-title":"Eng. Sci."},{"key":"10.1016\/j.phymed.2026.158611_bib0019","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.semcdb.2020.03.009","article-title":"Mammalian cell cycle cyclins","volume":"107","author":"Martinez-Alonso","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.phymed.2026.158611_bib0020","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1038\/s44319-025-00539-w","article-title":"Kif11-haploinsufficient oocytes reveal spatially differential requirements for chromosome biorientation","volume":"26","author":"Mishina","year":"2025","journal-title":"EMBo Rep."},{"key":"10.1016\/j.phymed.2026.158611_bib0022","article-title":"Oxypeucedanin: chemotaxonomy, isolation, and bioactivities","volume":"10","author":"Mottaghipisheh","year":"2021","journal-title":"Plants (Basel)"},{"key":"10.1016\/j.phymed.2026.158611_bib0023","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/a-2512-9183","article-title":"Fragment-based drug discovery of KIF11 inhibitors for glioblastoma treatment: molecular insights and therapeutic potential","volume":"75","author":"Naseer","year":"2025","journal-title":"Drug Res. (Stuttg)"},{"key":"10.1016\/j.phymed.2026.158611_bib0024","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2026.158611_bib0025","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrc3310","article-title":"Kinesins and cancer","volume":"12","author":"Rath","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2026.158611_bib0026","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1002\/cncr.30892","article-title":"A Phase 1 and 2 study of Filanesib alone and in combination with low-dose dexamethasone in relapsed\/refractory multiple myeloma","volume":"123","author":"Shah","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.phymed.2026.158611_bib0027","first-page":"26","article-title":"Kinesin Spindle Protein (KIF11) in mitosis and cancer","author":"Silva","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2026.158611_bib0028","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/s41594-025-01587-5","article-title":"Mechanisms for licensing origins of DNA replication in eukaryotic cells","volume":"32","author":"Stillman","year":"2025","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.phymed.2026.158611_bib0031","doi-asserted-by":"crossref","first-page":"i10","DOI":"10.1093\/annonc\/mdx703","article-title":"Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors","volume":"29","author":"Westover","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phymed.2026.158611_bib0032","article-title":"Macrophage efferocytosis mediated by the TP63-RAC2 pathway promotes immunosuppressive remodeling in esophageal cancer","volume":"7","author":"Xi","year":"2026","journal-title":"Cell Rep. Med."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326008421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326008421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:31:02Z","timestamp":1787553062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326008421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":28,"alternative-id":["S0944711326008421"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158611","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting KIF11 degradation: Oxypeucedanin inhibits lung adenocarcinoma progression by disrupting the MCM2-CDK1 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158611"}}